FindTrial
Sign In

Meige syndrome susceptibility and BTA efficacy research

Meige syndrome susceptibility and BTA efficacy research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCC-14004202
Enrollment
Unknown
Registered
2014-01-24
Start date
2014-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meige syndrome

Interventions

Meige snydrome patients:BTA 50U injection.
Healthy control:NA

Sponsors

Institution of Clinical Pharmacology, Cental South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To be diagnosed by neurologists Meige syndrome patients; 2. healthy controls.

Exclusion criteria

Exclusion criteria: non-Meige snydrome patients

Design outcomes

Primary

MeasureTime frame
maintain time;—

Countries

China

Contacts

Public ContactZhaoqian Liu

Institution of Clinical Pharmacology, CSU

liuzhaoqian63@126.com+86 13787797720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026